Mindfulness as a Predictor of Migraine-Related Disability: Evidence from a Cross-Sectional Study
Abstract
Background: Migraines are prevalent neurological disorders characterized by severe headaches, nausea, and heightened sensory sensitivities, often triggered by various environmental and physiological factors. Although not life-threatening, migraines can significantly impair daily functioning and are associated with increased cardiovascular risk, particularly in cases with aura. Aim: This study aimed to investigate the association between mindfulness and migraine-related disability and to explore whether mindfulness may alleviate migraine impact by reducing stress.
Methods: A cross-sectional design was employed involving 110 adults with clinically diagnosed migraines, aged 18 to 65 years, recruited through purposive sampling. Participants completed the Mindful Attention Awareness Scale and the Migraine Disability Assessment. Data were analyzed using descriptive statistics, Pearson’s product-moment correlation, and linear regression analyses.
Results: There was a significant negative correlation between mindfulness and migraine-related disability (r = −0.334, p<.001), indicating that higher mindfulness is associated with lower disability. Regression analysis confirmed mindfulness as a significant negative predictor of migraine-related disability (β=−0.334), accounting for 11.2% of the variance (R2=0.112).
Conclusion: These findings highlight the potential of mindfulness-based interventions as non-pharmacological strategies to reduce migraine-related disability by mitigating…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 110 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.